academic article

• A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis..  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.  20:832-838. 2016